| Literature DB >> 28299644 |
Bethany Grimmig1, Seol-Hee Kim1, Kevin Nash2, Paula C Bickford3,4, R Douglas Shytle1.
Abstract
Astaxanthin (AXT) is a carotenoid with multiple health benefits. It is currently marketed as a health supplement and is well known for its antioxidant capacity. Recent evidence has emerged to suggest a broad range of biological activities. The interest in this compound has increased dramatically over the last few years and many studies are now applying this molecule across many disease models. Results from the current research are beginning to come together to suggest neuroprotective properties including anti-inflammatory, anti-apoptotic, and antioxidant effects, as well as the potential to promote or maintain neural plasticity. These emergent mechanisms of actions implicate AXT as a promising therapeutic agent for neurodegenerative disease. This review will examine and extrapolate from the recent literature to build support for the use of AXT in mitigating neuropathy in normal aging and neurodegenerative disease.Entities:
Keywords: Aging; Astaxanthin; Microglial function; Neural plasticity; Neuroprotection
Mesh:
Substances:
Year: 2017 PMID: 28299644 PMCID: PMC5352583 DOI: 10.1007/s11357-017-9958-x
Source DB: PubMed Journal: Geroscience ISSN: 2509-2723 Impact factor: 7.713